Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:29:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    No substantive additions or deletions were detected in the study details; the page content remains the same.
    Difference
    0.0%
    Check dated 2026-02-21T09:07:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed on the page, indicating a minor site update. There are no observed changes to the study content, eligibility criteria, or navigation.
    Difference
    0.0%
    Check dated 2026-02-14T05:21:35.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0 on the page.
    Difference
    0.0%
    Check dated 2026-02-07T05:13:21.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The update includes minor administrative changes: a new 'Show glossary' option and page revision to v3.4.0 with updated timestamps (Last Update Submitted that Met QC Criteria, Last Update Posted) and a No FEAR Act Data note.
    Difference
    0.3%
    Check dated 2026-01-24T00:20:07.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a new revision label Revision: v3.3.4 replacing v3.3.3, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:32:07.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.